What's in Tasly Biopharmaceuticals Co., Ltd.'s pipeline?

Tasly Biopharmaceuticals Co., Ltd. has 7 drugs in our index: 0 marketed, 0 filed, 4 in Phase 3, 2 in Phase 2, 1 in Phase 1.

Which companies overlap with Tasly Biopharmaceuticals Co., Ltd.'s portfolio?

Top competitors by shared drug class: Beijing Tiantan Hospital, The George Institute, AJU Pharm Co., Ltd., Abbott, AceLink Therapeutics, Inc..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/tasly-biopharmaceuticals-co-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Tasly Biopharmaceuticals Co., Ltd. — Portfolio Competitive Intelligence Brief

Tasly Biopharmaceuticals Co., Ltd. pipeline: 0 marketed, 0 filed, 4 Phase 3, 2 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 4 Phase 3 2 Phase 2 1 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Recombinant human urokinase	Recombinant human urokinase	phase 3	Thrombolytic	Plasminogen	Cardiovascular
Aspirin simulation agent	Aspirin simulation agent	phase 3			Cardiovascular
rhPro-UK simulation agent	rhPro-UK simulation agent	phase 3	Fibrinolytic agent / Thrombolytic	Plasminogen / Fibrin	Cardiovascular / Thrombosis
rhPro-UK	rhPro-UK	phase 3	prokineticin-2 receptor agonist	prokineticin-2 receptor	Oncology

Therapeutic area mix

Cardiovascular · 2
Cardiovascular / Thrombosis · 1
Diabetes · 1
Oncology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Beijing Tiantan Hospital · 2 shared drug classes
The George Institute · 2 shared drug classes
AJU Pharm Co., Ltd. · 1 shared drug class
Abbott · 1 shared drug class
AceLink Therapeutics, Inc. · 1 shared drug class
Ache Laboratorios Farmaceuticos S.A. · 1 shared drug class
Aciex Therapeutics, Inc. · 1 shared drug class
AO GENERIUM · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Tasly Biopharmaceuticals Co., Ltd.:

Cite this brief

Drug Landscape (2026). Tasly Biopharmaceuticals Co., Ltd. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/tasly-biopharmaceuticals-co-ltd. Accessed 2026-05-16.